Bristol-Myers Squibb Cash Flow Statement

Operating, investing, and financing cash movements

Bristol-Myers Squibb generated $13.3B in operating cash flow over the trailing twelve months. After $1.4B in capital expenditures, free cash flow was $11.9B. Free cash flow decreased 0.1% year-over-year. Based on the Q1 2026 filing.